Maryland Oncology Hematology (MOH) ( Site 8000) is a clinical research site located in Columbia, Maryland, United States 21044.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Maryland Oncology Hematology (MOH) ( Site 8000) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Solid Tumors, Hematologic Malignancies.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Maryland Oncology Hematology (MOH) ( Site 8000) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Maryland Oncology Hematology (MOH) ( Site 8000) has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumors, Hematologic Malignancies.
Maryland Oncology Hematology (MOH) ( Site 8000) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.